Apyx Medical Corporation Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Apyx Medical Corporation Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Outlook

Apyx Medical Corp. (APYX) Tops Q4 EPS by 7c, Revenues Beat; Offers FY21 Revenues Guidance Below Consensus

March 31, 2021 7:03 AM EDT

Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.04), $0.07 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $11.5 million versus the consensus estimate of $9.62 million.

Fourth Quarter 2020 Financial Summary:

Total revenue of $11.5 million, up 36.8% year-over-year.Advanced Energy revenue of $9.9 million, up 44.0% year-over-year.OEM revenue of $1.6 million, up 4.0% year-over-year.Net loss of $1.5 million, compared to net loss of $5.4 million for the fourth quarter of 2019.Adjusted EBITDA loss of $0.7 million, compared to adjusted EBITDA loss of $4.8 million for the fourth quarter of... More